@BillGates: A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease. https://t.co/h97EBGqWyJ
http://twitter.com/BillGates
A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease. https://t.co/h97EBGqWyJ
— Bill Gates (@BillGates) October 30, 2019
Comments
Post a Comment